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Inhibition of protein crystallization by evolutionary negative design
Jonathan P. K. Doye,∗ Ard A. Louis,† and Michele Vendruscolo‡
University Chemical Laboratory, Lensfield Road, Cambridge CB2 1EW, United Kingdom
(Dated: November 17, 2018)
In this perspective we address the question: why are proteins seemingly so hard to crystallize?
We suggest that this is because of evolutionary negative design, i.e. proteins have evolved not
to crystallize, because crystallization, as with any type of protein aggregation, compromises the
viability of the cell. There is much evidence in the literature that supports this hypothesis, including
the effect of mutations on the crystallizability of a protein, the correlations found in the properties
of crystal contacts in bioinformatics databases and the positive use of protein crystallization by
bacteria and viruses.
PACS numbers: 87.15Nn,87.14Ee
The overwhelming impression one gets from reading
the literature on protein crystallization and listening to
experts is that protein crystallization is difficult and re-
quires considerable effort. Furthermore, experience and
a certain feeling for what might work can play a crucial
role. Recent technical innovations,1 such as the avail-
ability of scanning kits which codify experience to scour
for appropriate crystallization conditions, have helped to
provide valuable savings in labour. These advances, how-
ever, have not altered what seems to be the basic fact:
Proteins, for the most part, do not seem to want to crys-
tallize, and have to be coaxed into doing so through the
use of suitable cunning.
This situation is particularly vexing, because protein
crystallization is a vital step in protein structure deter-
mination, and hence to structural genomics initiatives,2
which seek to catalogue the protein structures associated
with the whole genome of a target organism. Although
there are also obstacles associated with the expression
and purification of the proteins, crystallization is often
labelled as the major bottleneck in this process.3
The quantification of some of the difficulties involved in
protein crystallization is beginning to emerge from struc-
tural genomics pilot studies. Generally, the output of new
protein structures so far has been “disappointingly low”.4
For example, for a thermophilic prokaryote, probably the
class of organisms for which the greatest success rate is
expected, only 13% of a target set of non-membrane pro-
teins were estimated to be readily amenable to structural
determination; at present only 4% of the structures of
these proteins have actually been obtained.5 These suc-
cesses probably represent the “low-hanging fruits” of the
proteome. How to reach higher branches remains un-
clear.
In this perspective, we would like to take a step back
and offer our opinions on an important question raised
by this situation: Why is the crystallization of proteins
so difficult? This is not only a fundamental question,
but also a practical one. A natural starting point for any
rational attempt to overcome the obstacles that hinder
protein crystallization is to first understand the nature
of these barriers.
In general, one expects that it should be possible to
obtain crystals for soluble molecules that have a well-
defined structure.6 So why should globular proteins be
any different? One possible answer is that proteins are
polypeptide chains with significant conformational en-
tropy and this will have some effect on their crystal-
lization properties. However, their dynamic nature does
not interfere with their ability to form specific complexes
with proteins and other molecules.
In our opinion, the answer to this question lies in
the evolutionary origin of proteins. Proteins are a very
special type of polymer and their possible states are
different from those of normal polymers. For exam-
ple, simple homopolymers can be either in a swollen
or a collapsed phase, depending on the quality of the
solvent.7 But whereas proteins in a collapsed globular
state can remain soluble for appreciable concentrations,
collapsed homopolymers aggregate very easily. There
are, of course, many more differences between simple
polymers and proteins. Here we suggest that evolution
appears to have enhanced the tendency to keep globular
proteins soluble and active, reducing the probability of
realizing all types of aggregate states.
Our hypothesis is thus that proteins have evolved not
to crystallize, because crystallization, as well as any
type of aggregation, compromises the viability of the
cell. Most aggregation diseases, e.g. Alzheimer’s and
Creutzfeldt-Jakob disease, are associated with non-native
protein structures, and the cell has developed sophisti-
cated quality control mechanisms to cope with misfolded
proteins.8 However, there are also a number of diseases
associated with the aggregation of proteins in their na-
tive state. Perhaps the best known example is sickle cell
anaemia, where a mutant form of hemoglobin coalesces
to form ordered fibrillar aggregates inside red blood cells.
In addition, there are also instances of diseases that re-
sult from crystallization: Certain forms of cataracts and
anaemia are caused by crystallization of mutant forms of
the γ crystallin9 and hemoglobin10 proteins, respectively.
Furthermore, protein crystallization has been found to be
associated with other pathologies11. In general, however,
such diseases are less common that those associated with
the aggregation of misfolded proteins. We suggest that
this difference is because the well-defined structure of the
2native state makes it much more amenable to evolution-
ary control.
One further consideration is that the selection pres-
sure is with respect to crystallization in vivo, whereas
protein crystallographers explore far-from-physiological
conditions in vitro. However, in our view, the fact that
crystallization is difficult even in the latter circumstances
simply reflects the robustness of the strategies used by
nature to ensure that proteins do not crystallize in the
cellular environment.
Our hypothesis is one example of a negative design
principle. More often we think in terms of positive de-
sign, i.e. that the sequence of a protein has been opti-
mized through evolution to give the protein particular
characteristics. However, negative design leading to the
avoidance of unwanted properties, such as crystallizabil-
ity or aggregation, can be equally important.
Such negative design principles have been previously
proposed for both the single-molecule and intermolecu-
lar properties of proteins. For example, for a protein
to fold reliably to its native state, not only must the
native structure be particularly low in free energy, but
alternative conformations must also not have similar or
lower stability.12 Some of the strategies by which this
specificity can be achieved have been identified and then
applied in the de novo design of proteins.13 For exam-
ple, even though it is generally more thermodynamically
favourable to have hydrophobic residues in the core of
the protein, greater specificity can be achieved by the
introduction of some interacting polar residues into the
core.14
Lessons on negative design can be learnt from the ne-
cessity to avoid aggregation. This is a particular problem
for proteins involving β-sheets, since their edges are nat-
ural sites for association with other β-sheets in nearby
proteins, and, for example, can lead to the extended β-
sheet structures found in amyloid deposits. A number
of negative design strategies have been found in natu-
ral proteins that protect β-sheet edges.15 The simplest
strategy is to form a continuous β-sheet structure with-
out any edges, as in β-barrels. Another of the identified
strategies has been successfully applied to turn an aggre-
gating protein into a soluble monomeric form by a single
mutation of a non-polar residue to lysine.16
Designing out unwanted interactions is also necessary
in molecular recognition. To achieve specificity, a protein
must not only interact strongly with the target molecule,
but also have much less favourable interactions with all
other molecules.17,18
The two examples discussed above illustrate the com-
bination of positive and negative design that is used to
tailor the interprotein interactions. Most generally, this
is seen in the remarkable properties of cellular solutions,
where crowded, multi-component mixtures with protein
packing fractions of up to 40%19 can be both functionally
active and stable. By contrast, any attempt to make ar-
tificial nanocolloidal mixtures of similar density is bound
to result in components sticking together to form an
amorphous deposit. In fact, colloid scientists expend
considerable effort modifying the surfaces of colloids—
adding, for example, charged groups or short polymer
brushes—to prevent this from occurring. To achieve this
combination of specific attraction (positive design) and
generic repulsion (negative design), evolution must exert
remarkable control over the matrix of all possible inter-
protein interactions.20,21 In this context, our hypothesis
concerns a particular type of interaction (namely crystal-
forming) that contributes to the diagonal elements (i.e.
self-interactions) of this matrix.
Let us consider how this negative design might be
achieved. As many amino acid sequences can give rise to
the same final protein fold, there is considerably freedom
in how the amino acids, particularly those on the surface
of the protein,22 are chosen. This flexibility could po-
tentially allow the protein surface to be organized such
that crystallization is hindered, without affecting either
the structure of the protein’s fold or its active site.
Importantly, such a scenario has testable consequences.
If the surfaces of proteins have been optimized to suffi-
ciently reduce their crystallizability, one would expect
that random mutations of the surface amino acids that
do not alter the structure of the protein fold or its activity
(i.e. only the ‘neutral’ mutations that are evolutionarily
allowed) would be likely to lead to a more crystallizable
protein. By contrast, if our hypothesis did not apply and
a protein’s crystallizability did not influence the choice
of surface amino acids, one would expect such mutants
to be as likely to hinder as to enhance a protein’s crys-
tallizability.
We know of two such systematic studies of the crys-
tallizability of mutagens, the first on human thymidylate
synthase23 and the second on a fragment of the DNA gy-
rase B subunit from Escherichia Coli.24 In both studies,
mutations were found to have a dramatic effect on the
crystallization properties of the protein. In agreement
with our negative design hypothesis, the mutants gen-
erally showed enhanced crystallizability compared to the
wild-type, as measured by the number of hits in a crystal-
lization screen. There was also evidence of enhancement
in crystal quality. Moreover, some of the mutants crys-
tallized in space groups that were not encountered for the
wild-type protein. Although the amount of data is not
enough to provide conclusive justification of our negative
design argument, it is strongly suggestive. Furthermore,
there is a body of more anecdotal evidence consistent
with our ideas, namely the growing catalogue of proteins
that have been first crystallized as mutants.25
By contrast, where there has been positive design of
the protein surface, as in the case of specific functional
binding interactions between two proteins, one would ex-
pect random mutagenesis to lead on average to a reduc-
tion in the binding affinity between the proteins. This is
indeed the case, and such studies have played an impor-
tant role in understanding the nature of protein-protein
binding through the identification of small sets of residues
that are key to the stability of the interface.26
3Although it seems clear that the surfaces of proteins
have been designed to hinder crystallization, there still
remains the question of what physical mechanism un-
derlies the reduced crystallizability of the evolutionary
selected protein surfaces. One might guess that this be-
haviour reflects some complex property of the surface,
and hence would be hard to identify or rationally control.
However, there is experimental evidence that surface ly-
sine residues could play a key role in this negative design
strategy.
As one would expect for a charged amino acid, lysine
prefers to be at the surface of the protein, where it can
interact with the aqueous environment. In fact, lysine
has the highest propensity to be at the surface of all the
amino acids and is the most common surface residue.27
Lysine is also unique in presenting the largest amount
of solvent accessible surface area that is hydrophobic in
character,28 because of the long hydrophobic tail that
links the amine group to the protein backbone. Even
more interestingly for our present considerations, sys-
tematic studies of interprotein contacts have found ly-
sine to be the most underrepresented amino acid at crys-
tal contacts,29,30 and even more so at the interfaces be-
tween subunits of protein oligomers29 and between pro-
teins that form functional complexes.31,32 These negative
correlations of course raise questions concerning the pur-
pose of lysine residues: Why are they so abundant on the
surface, if they are only reluctantly involved in functional
interactions? It could be that lysine plays an impor-
tant negative role in regulating interprotein interactions
through preventing unwanted interactions. Indeed, Das-
gupta et al. suggested the mutation of lysine residues as
a rational strategy for enhancing crystallizability.29
Just such an approach has been implemented in the
experiments of the Derewenda group.33,34,35,36 They con-
sidered the effects of a series of lysine to alanine muta-
tions for human RhoGDI.33 Their rationale for this par-
ticular type of mutation was that the substitution of an
amino acid with high conformational entropy by a smaller
one would lead to a reduction in the entropy loss on crys-
tal contact formation. Whether for this reason or not—
the replacement of a charged amino acid by a neutral one
will also lead to concomitant changes in the electrostatic
interactions—the results were dramatic. The mutants in-
variably showed enhanced crystallizability, and often pro-
duced crystals that diffracted to higher resolution than
achievable otherwise. Consistent with the idea that the
lysine residues somehow prevent unwanted interactions,
new crystal contacts were often formed at the sites of the
mutations. A similar study on glutamate to alanine mu-
tations also revealed enhanced crystallizability, although
not quite to the same degree.36 This rational mutagenesis
strategy has since been successfully applied to crystallize
proteins of previously unknown structure.34,35
Additional support for the idea that negative design
is a key aspect of evolution at the molecular level comes
from instances where one of the assumptions of our hy-
pothesis does not hold; namely, that crystallization is
harmful to the cell. Although this assumption is likely
to be generally true, it is a simplification and will not
necessarily hold for all cellular environments. In the ab-
sence of such a selection pressure, crystallization is likely
to be significantly easier. Indeed, there may even be
circumstances when crystallization is a positive advan-
tage. For example, a crystal may provide an efficient
and convenient way to store a protein. Anecdotal ev-
idence for this correlation between crystallizability and
function can perhaps be found in the history of protein
crystallization,11 as it is reasonable to expect that pro-
teins that were among the first to be crystallized are at
the easier end of the spectrum of crystallizability. For ex-
ample, storage proteins, particularly the globulins found
in seeds and nuts, were amongst the earlier protein crys-
tals to be discovered, although this, at least partly, also
reflects the ready availability of a protein source.
More direct evidence for this potential positive side to
crystallization comes from the identification of crystals
in vivo, an interesting overview of which is given in Ref.
11. For example, protein crystals have been observed in
the egg yolks of various organisms, and ribosome crys-
tals have been found in hibernating animals, presumably
because they act as a temporary reservoir for this im-
portant cellular component. Particularly interesting in
this regard is the Bacillus thuringiensis class of bacteria,
which produce protein toxins specific to a wide variety
of insects.37 Crystals provide a particularly stable (up to
periods of years) form for these bacteria to store these
toxins. When ingested, these crystals dissolve, releasing
the toxins to attack the gut wall of the target insect, thus
facilitating the entry of germinating bacterial spores into
the host.
Although perhaps harmful to the host cell, there seems
little reason why the formation of crystals of virus par-
ticles would be disadvantageous to the virus. Indeed, it
probably presents a convenient way to densely pack the
particles and so minimize possible constraints on self-
replication. Consistent with this supposition, crystals of
spherical and icosahedral viruses are frequently observed
in infected cells. Furthermore, viruses were also amongst
the earlier biological particles to be crystallized.
Even more fascinating is the ingenious use of protein
crystallization made by viruses that are able to form a
quiescent state by embedding themselves in a protein
crystal matrix.38 These viruses cause large quantities of
an easily crystallizable protein to be expressed in an in-
fected cell. Nucleation of crystals of this protein then
occurs on the surface of the viral particles, surrounding
them by crystal and providing the viruses with a protec-
tive environment until further transmission is possible.
Similar to the bacterial toxins, these crystals readily dis-
solve in the gut of the insect host, releasing the virus.
The important lesson from these examples is that when
it is beneficial for the organism, nature seems to have no
difficulty enabling proteins to crystallize. Indeed, such
crystals can form spontaneously in the cell simply when
the concentration is sufficiently high without the need
4for extremely high purities and a series of precipitants to
drive the process. The contrasting difficulty that most
proteins have in crystallizing, therefore, does not seem to
be an intrinsic property of polypeptide chains that have
a well-defined folded structure. Rather, it is a property
that has been selected by nature, because of the need for
the protein-protein interactions to be strictly controlled
if the cell is to function properly.
Our arguments are not undermined by the fact that
proteins show a whole spectrum of crystallizabilities,
with proteins such as lysozymes, hemoglobins and in-
sulins at the easier end. This is to be expected from our
perspective. Firstly, as we have seen, the strength of the
selection pressure against crystallization may vary con-
siderably (and even be reversed) depending on the func-
tion and environment experienced by the protein. Sec-
ondly, evolution has no interest in controlling the prop-
erties of proteins in non-physiological conditions, and so
one should not expect a uniform response. Instead, the
degree to which the in vivo low crystallizability carries
over to in vitro environments is likely to show significant
variability. Lastly, evolution just requires the crystalliz-
ability to be low enough to pose only a low risk to the cell.
But there is no reason why the crystallizability could not
be significantly below this threshold value, as long as it
is not achieved at the expense of the other properties of
the protein.
Because the individual concentrations for the majority
of proteins are very low relative to the overall protein
concentration, some might argue that the putative nega-
tive design acts most directly against the non-specific ag-
gregation of native proteins, and then, perhaps because
the mechanisms used are generic, only indirectly against
crystallization. Indeed, the evidence that we have pre-
sented for negative design with respect to crystallization
does not indicate whether this effect is direct or indirect.
Moreover, the typical cellular concentration of a protein
in the cell will be one of the factors that determines the
magnitude of the selection pressure against crystalliza-
tion. However, it should also be remembered that low
concentrations do not prevent functional interactions be-
tween proteins, and that the coexistence line between
crystal and dilute solution in a protein phase diagram
can occur at very low concentrations.39 In our opinion,
the negative design against crystallization is probably a
mixture of direct and indirect effects.
In this article we have presented a different perspective
by which to rationalize the crystallizability of proteins.
Progress towards enhancing the success rate of crystalliz-
ing proteins will depend on unravelling the mechanisms
by which nature achieves this negative design. We have
highlighted several studies which show that random mu-
tations enhance crystallizability. Mutagenesis programs
have already led to important new insights into the na-
ture of the functional interactions between proteins26 and
the key determinants of the propensity for amyloidogenic
aggregation.40 Similar systematic studies may provide an
important means for understanding the mechanisms by
which proteins are prevented from crystallizing. This
would have the potential not only to provide further con-
firmation of our negative design hypothesis, but also to
reveal residues and surface patterns that are key for the
formation or prevention of crystal contacts.
We have already highlighted some interesting results
that flag the potentially important role played by lsyine
residues. Further, more detailed physical studies of
the mechanisms by which lysine influences the protein-
protein interactions would be desirable. For example, it
would be interesting to see how the second virial coeffi-
cient, a measure of the strength of the generic attractions
between proteins, changes with the mutation of surface
lysine residues. Computer simulations could also poten-
tially provide a more detailed atomistic picture of the
conformations adopted by a surface lysine and how this
changes with crystal contact formation.
Obtaining a better understanding of the mechanisms
used to hinder crystallization would open up the possi-
bility of finding ways to “turn off” these negative inter-
actions, and so enhance a protein’s crystallizability. The
required changes to the surface properties could perhaps
be achieved through mutations or the addition of appro-
priate precipitants. Furthermore, such advances in our
understanding of protein crystallization could also po-
tentially rationalize the effects of some of the precipitants
currently used. At best, the effects of these precipitants
are understood only in terms of their effect on average
properties, such as the second virial coefficient. How-
ever, the mechanisms underlying some, e.g. polyethylene
glycol, remain rather mysterious.
Finally, we note that only positive outcomes of pro-
tein crystallization experiments have traditionally been
published. In our opinion, experiments where crystalliz-
ability is reduced rather than enhanced may also contain
useful information about the mechanisms of negative de-
sign. Thinking in terms of this principle may help ex-
perimentalists decide when such “negative” results are
nevertheless valuable.
To summarize, we have presented a perspective on pro-
tein crystallization whereby the difficulty crystallogra-
phers have in obtaining protein crystals is a consequence
of evolutionary negative design against aggregation of
native-state proteins. It really is the case that proteins
do not want to crystallize because a protein that is prone
to crystallization, or in fact any form of aggregation, is
potentially deleterious to the cell. The mechanisms of
this negative design are only very partially understood.
But our main point is that understanding these mecha-
nisms of negative design should provide fruitful insights
that lead to positive advances in crystallizing globular
proteins.
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